Skip to main content
Log in

Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials

  • Commentary
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–31. https://doi.org/10.1016/S1474-4422(12)70104-7.

    Article  CAS  PubMed  Google Scholar 

  2. Bian L, Zhang J, Wang M, Keep RF, Xi G, Hua Y. Intracerebral hemorrhage-induced brain injury in rats: the role of extracellular Peroxiredoxin 2. Transl Stroke Res. 2020;11(2):288–95. https://doi.org/10.1007/s12975-019-00714-x.

    Article  PubMed  Google Scholar 

  3. Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42(11):3067–74. https://doi.org/10.1161/STROKEAHA.111.617589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019;18(5):428–38. https://doi.org/10.1016/S1474-4422(19)30069-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wei C, Wang J, Foster LD, Yeatts SD, Moy C, Mocco J, Selim M; i-DEF Investigators. Effect of Deferoxamine on outcome according to baseline hematoma volume: a post hoc analysis of the i-DEF trial. Stroke. 2021 Nov. 18:STROKEAHA121035421. https://doi.org/10.1161/STROKEAHA.121.035421.

  6. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. https://doi.org/10.1056/NEJMoa1214609.

    Article  CAS  PubMed  Google Scholar 

  7. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–43. https://doi.org/10.1056/NEJMoa1603460.

    Article  PubMed  PubMed Central  Google Scholar 

  8. European Stroke Initiative Writing C, Writing Committee for the EEC, Steiner T, Kaste M, Forsting M, Mendelow D, et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage the European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis. 2006;22(4):294–316. https://doi.org/10.1159/000094831.

    Article  Google Scholar 

  9. Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60. https://doi.org/10.1161/STR.0000000000000069.

    Article  PubMed  Google Scholar 

  10. Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021–32. https://doi.org/10.1016/S0140-6736(19)30195-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

YH, RFK, SK and GX were supported by grants NS-007222, NS-096917, NS106746, NS112394 and NS116786 from the National Institutes of Health (NIH). KGH was supported by a research fellowship grant from Neurosurgery Research & Education Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guohua Xi.

Ethics declarations

Ethical approval

Not applicable

Conflict of interest

Fenghui Ye, Yingfeng Wan, Sravanthi Koduri, Katherine G. Holste, Richard F. Keep, Ya Hua and Guohua Xi declare that they have no conflict of interest.

Guohua Xi is Deputy Editor-in-Chief of Translational Stroke Research.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, F., Wan, Y., Koduri, S. et al. Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials. Transl. Stroke Res. 14, 281–282 (2023). https://doi.org/10.1007/s12975-022-01013-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-022-01013-8

Navigation